Table 5.

Comparing high and low composite adherence, stratified by race

	African American			Caucasian
	High (n = 23)	Low (n = 53)	P value	High (n = 23)	Low (n = 22)	P value
Hurried communication, a median[IQR]	1.1[1‐1.5]	1.5[1‐1.8]	0.07	1[1‐1.5]	1[1‐1.5]	0.7
Hard words, median[IQR]	1[1‐2]	2[1‐2]	0.04	1[1‐2]	1[1‐2]	0.7
Doctor ignore, median[IQR]	1[1‐1]	1[1‐2]	0.05	1[1‐1]	1[1‐1]	0.7
Doctor distracted, median[IQR]	1[1‐1]	1[1‐1]	0.07	1[1‐1]	1[1‐1]	0.7
Compassionate respectful, a median[IQR]	5[5‐5]	5[4‐5]	0.02	5[4.4‐5]	5[4.2‐5]	0.6
Compassionate, median[IQR]	5[5‐5]	5[4‐5]	0.05	5[4‐5]	5[4‐5]	0.5
Concerned, median[IQR]	5[5‐5]	5[4‐5]	0.04	5[4‐5]	5[4‐5]	0.6
Discrimination, a median[IQR]	1[1‐1]	1[1‐1]	0.8	1[1‐1.5]	1[1‐1]	0.06
Assume income, median[IQR]	1[1‐1]	1[1‐1]	1	1[1‐1]	1[1‐1]	0.09
Negative effect, median[IQR]	13[11‐16]	16[13‐21]	0.02	16[12‐21]	16[12‐21]	0.8
Anxiety, b median [IQR]	43[40‐58]	54[40‐60]	0.04	51[40‐56]	50[40‐59]	0.6
Social health, b median[IQR]	54(9)	50 (10)	0.06	46(11)	47 (10)	0.4
>2 SLE medications	65%	84%	0.09	39%	77%	0.01
SLE regimen complexity, median[IQR]	7[3‐11]	8[5‐10]	0.6	3[3‐7]	7[3‐9]	0.03
SLEDAI, median[IQR]	2[0‐4]	4[2‐6]	0.06	2[0‐4]	0[0‐4]	0.8
SLAQ, median[IQR]	6[4‐11]	9[5‐13]	0.06	8[4‐12]	12[8‐18]	0.04
Fibromyalgia pain, mean (SD)	4.4 (3.3)	4.6 (3.0)	0.4	4.4 (3.1)	6.2 (2.7)	0.04

Abbreviation: IPC‐29, Interpersonal Processes of Care Survey with 29 questions; IPC‐29, Interpersonal Processes of Care Survey with 29 questions; IQR, interquartile range; PROMIS, Patient‐Reported Outcomes Measurement Information System; SD, standard deviation; SLAQ, Systemic Lupus Activity Questionnaire; SLE, systemic lupus erythematosus; SLEDAI, SLE Disease Activity Index.

^aIPC‐29 survey, score ranges from 1 to 5, 1 is best for “Hurried communication” and “Discrimination,” 5 is best for “Compassionate respectful.”

^bPROMIS measures, reference population mean score is 50, clinically significant difference is 5; a higher score indicates more of the domain.

Bolded values indicate p‐value <0.05.